0.0237
Galera Therapeutics Inc (GRTX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 |
Research and Development |
19.42%
6.093
|
7.561 | 7.272 |
Interest Income/Expense |
147.44%
-2.087
|
4.399 | 4.223 |
Operating Income/Loss |
20.30%
-13.40
|
-16.81 | -13.88 |
Income/Loss From Continuing Operations Before Tax |
27.23%
-15.07
|
-20.71 | -17.71 |
Income/Loss From Continuing Operations After Tax |
27.23%
-15.07
|
-20.71 | -17.71 |
|
27.23%
-15.07
|
-20.71 | -17.71 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - |
Attributable To Noncontrolling Interest |
-
|
- | - |
Basic Average Shares |
5.97%
45.48
|
42.92 | 35.20 |
Diluted Average Shares |
5.97%
45.48
|
42.92 | 35.20 |
Basic Earnings Per Share |
31.25%
-0.33
|
-0.48 | -0.50 |
Diluted Earnings Per Share |
168.75%
-0.33
|
0.48 | -0.50 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - |
大文字化:
|
ボリューム (24 時間):